Cargando…

Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility

The ketone body 3-hydroxybutyrate (3-OHB) increases cardiac output and myocardial perfusion without affecting blood pressure in humans, but the cardiovascular sites of action remain obscure. Here, we test the hypothesis in rats that 3-OHB acts directly on the heart to increase cardiac contractility...

Descripción completa

Detalles Bibliográficos
Autores principales: Homilius, Casper, Seefeldt, Jacob Marthinsen, Axelsen, Julie Sørensen, Pedersen, Tina Myhre, Sørensen, Trine Monberg, Nielsen, Roni, Wiggers, Henrik, Hansen, Jakob, Matchkov, Vladimir V., Bøtker, Hans Erik, Boedtkjer, Ebbe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492777/
https://www.ncbi.nlm.nih.gov/pubmed/37688627
http://dx.doi.org/10.1007/s00395-023-01008-y
_version_ 1785104329310470144
author Homilius, Casper
Seefeldt, Jacob Marthinsen
Axelsen, Julie Sørensen
Pedersen, Tina Myhre
Sørensen, Trine Monberg
Nielsen, Roni
Wiggers, Henrik
Hansen, Jakob
Matchkov, Vladimir V.
Bøtker, Hans Erik
Boedtkjer, Ebbe
author_facet Homilius, Casper
Seefeldt, Jacob Marthinsen
Axelsen, Julie Sørensen
Pedersen, Tina Myhre
Sørensen, Trine Monberg
Nielsen, Roni
Wiggers, Henrik
Hansen, Jakob
Matchkov, Vladimir V.
Bøtker, Hans Erik
Boedtkjer, Ebbe
author_sort Homilius, Casper
collection PubMed
description The ketone body 3-hydroxybutyrate (3-OHB) increases cardiac output and myocardial perfusion without affecting blood pressure in humans, but the cardiovascular sites of action remain obscure. Here, we test the hypothesis in rats that 3-OHB acts directly on the heart to increase cardiac contractility and directly on blood vessels to lower systemic vascular resistance. We investigate effects of 3-OHB on (a) in vivo hemodynamics using echocardiography and invasive blood pressure measurements, (b) isolated perfused hearts in Langendorff systems, and (c) isolated arteries and veins in isometric myographs. We compare Na-3-OHB to equimolar NaCl added to physiological buffers or injection solutions. At plasma concentrations of 2–4 mM in vivo, 3-OHB increases cardiac output (by 28.3±7.8%), stroke volume (by 22.4±6.0%), left ventricular ejection fraction (by 13.3±4.6%), and arterial dP/dt(max) (by 31.9±11.2%) and lowers systemic vascular resistance (by 30.6±11.2%) without substantially affecting heart rate or blood pressure. Applied to isolated perfused hearts at 3–10 mM, 3-OHB increases left ventricular developed pressure by up to 26.3±7.4 mmHg and coronary perfusion by up to 20.2±9.5%. Beginning at 1–3 mM, 3-OHB relaxes isolated coronary (EC(50)=12.4 mM), cerebral, femoral, mesenteric, and renal arteries as well as brachial, femoral, and mesenteric veins by up to 60% of pre-contraction within the pathophysiological concentration range. Of the two enantiomers that constitute racemic 3-OHB, D-3-OHB dominates endogenously; but tested separately, the enantiomers induce similar vasorelaxation. We conclude that increased cardiac contractility and generalized systemic vasorelaxation can explain the elevated cardiac output during 3-OHB administration. These actions strengthen the therapeutic rationale for 3-OHB in heart failure management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00395-023-01008-y.
format Online
Article
Text
id pubmed-10492777
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-104927772023-09-11 Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility Homilius, Casper Seefeldt, Jacob Marthinsen Axelsen, Julie Sørensen Pedersen, Tina Myhre Sørensen, Trine Monberg Nielsen, Roni Wiggers, Henrik Hansen, Jakob Matchkov, Vladimir V. Bøtker, Hans Erik Boedtkjer, Ebbe Basic Res Cardiol Original Contribution The ketone body 3-hydroxybutyrate (3-OHB) increases cardiac output and myocardial perfusion without affecting blood pressure in humans, but the cardiovascular sites of action remain obscure. Here, we test the hypothesis in rats that 3-OHB acts directly on the heart to increase cardiac contractility and directly on blood vessels to lower systemic vascular resistance. We investigate effects of 3-OHB on (a) in vivo hemodynamics using echocardiography and invasive blood pressure measurements, (b) isolated perfused hearts in Langendorff systems, and (c) isolated arteries and veins in isometric myographs. We compare Na-3-OHB to equimolar NaCl added to physiological buffers or injection solutions. At plasma concentrations of 2–4 mM in vivo, 3-OHB increases cardiac output (by 28.3±7.8%), stroke volume (by 22.4±6.0%), left ventricular ejection fraction (by 13.3±4.6%), and arterial dP/dt(max) (by 31.9±11.2%) and lowers systemic vascular resistance (by 30.6±11.2%) without substantially affecting heart rate or blood pressure. Applied to isolated perfused hearts at 3–10 mM, 3-OHB increases left ventricular developed pressure by up to 26.3±7.4 mmHg and coronary perfusion by up to 20.2±9.5%. Beginning at 1–3 mM, 3-OHB relaxes isolated coronary (EC(50)=12.4 mM), cerebral, femoral, mesenteric, and renal arteries as well as brachial, femoral, and mesenteric veins by up to 60% of pre-contraction within the pathophysiological concentration range. Of the two enantiomers that constitute racemic 3-OHB, D-3-OHB dominates endogenously; but tested separately, the enantiomers induce similar vasorelaxation. We conclude that increased cardiac contractility and generalized systemic vasorelaxation can explain the elevated cardiac output during 3-OHB administration. These actions strengthen the therapeutic rationale for 3-OHB in heart failure management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00395-023-01008-y. Springer Berlin Heidelberg 2023-09-09 2023 /pmc/articles/PMC10492777/ /pubmed/37688627 http://dx.doi.org/10.1007/s00395-023-01008-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Contribution
Homilius, Casper
Seefeldt, Jacob Marthinsen
Axelsen, Julie Sørensen
Pedersen, Tina Myhre
Sørensen, Trine Monberg
Nielsen, Roni
Wiggers, Henrik
Hansen, Jakob
Matchkov, Vladimir V.
Bøtker, Hans Erik
Boedtkjer, Ebbe
Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
title Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
title_full Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
title_fullStr Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
title_full_unstemmed Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
title_short Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
title_sort ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492777/
https://www.ncbi.nlm.nih.gov/pubmed/37688627
http://dx.doi.org/10.1007/s00395-023-01008-y
work_keys_str_mv AT homiliuscasper ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT seefeldtjacobmarthinsen ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT axelsenjuliesørensen ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT pedersentinamyhre ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT sørensentrinemonberg ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT nielsenroni ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT wiggershenrik ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT hansenjakob ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT matchkovvladimirv ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT bøtkerhanserik ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility
AT boedtkjerebbe ketonebody3hydroxybutyrateelevatescardiacoutputthroughperipheralvasorelaxationandenhancedcardiaccontractility